Here, we characterize for the first time the longitudinal outcome of circulating fetuin-A concentrations in nonobese adolescents with PCOS and show that fetuin-A levels normalize after treatment with a low-dose combination of insulin sensitizers and an antiandrogen, but not after OC. The gene discussed is AHSG; the disease is polycystic ovary syndrome.